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Abstract
Background—Traditional metrics of lung disease such as those derived from spirometry and 
static single-volume CT images are used to explain respiratory morbidity in patients with chronic 
obstructive pulmonary disease (COPD), but are insufficient. We hypothesized that the mean 
Jacobian determinant, a measure of local lung expansion and contraction with respiration, would 
contribute independently to clinically relevant functional outcomes.
Methods—We applied image registration techniques to paired inspiratory-expiratory CT scans 
and derived the Jacobian determinant of the deformation field between the two lung volumes to 
map local volume change with respiration. We analyzed 490 participants with COPD with 
multivariable regression models to assess strengths of association between traditional CT metrics 
of disease and the Jacobian determinant with respiratory morbidity including dyspnea (mMRC), St 
Georges Respiratory Questionnaire (SGRQ) score, six-minute walk distance (6MWD), and the 
BODE index, as well as all-cause mortality.
Corresponding author: Surya P. Bhatt, MD, University of Alabama at Birmingham, Division of Pulmonary, Allergy and Critical Care 
Medicine, THT 422, 1720, 2nd Avenue South, Birmingham, AL 35294. sbhatt@uabmc.edu. Phone: 205-996-6864. Fax: 
205-934-6229.
*Co-first authors, contributed equally to the manuscript.
Author Contributions: Study concept and design: Bhatt, Bodduluri and Reinhardt
Acquisition, analysis, or interpretation of data: All authors
Drafting of the manuscript: Bodduluri and Bhatt
Critical revision of the manuscript for important intellectual content: All authors
Statistical analysis: Bodduluri and Bhatt
Study supervision: All authors
Trial Registration: ClinicalTrials.gov: Identifier: NCT00608764
HHS Public Access
Author manuscript
Thorax. Author manuscript; available in PMC 2018 May 01.
Published in final edited form as:
Thorax. 2017 May ; 72(5): 409–414. doi:10.1136/thoraxjnl-2016-209544.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Results—The Jacobian determinant was significantly associated with SGRQ (adjusted regression 
co-efficient β = −11.75,95%CI −21.6 to −1.7;p=0.020), and with 6MWD (β=321.15, 95%CI 
134.1 to 508.1;p<0.001), independent of age, sex, race, body-mass-index, FEV1, smoking pack-
years, CT emphysema, CT gas trapping, airway wall thickness, and CT scanner protocol. The 
mean Jacobian determinant was also independently associated with the BODE index (β= −0.41, 
95%CI −0.80 to −0.02; p = 0.039), and mortality on follow-up (adjusted hazards ratio = 4.26, 
95%CI = 0.93 to 19.23; p = 0.064).
Conclusion—Biomechanical metrics representing local lung expansion and contraction improve 
prediction of respiratory morbidity and mortality and offer additional prognostic information 
beyond traditional measures of lung function and static single-volume CT metrics.
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Background
Airflow obstruction is the hallmark of chronic obstructive pulmonary disease (COPD); 
however, computed tomography (CT) is increasingly used to characterize and phenotype 
subtypes of COPD.1 The major subtypes of structural lung disease visualized on CT, 
emphysema and thickened airway walls, are both independently associated with airflow 
obstruction.23 These metrics of disease on CT have also been shown to be associated with 
important patient-reported and objective outcomes such as dyspnea,4 quality of life,56 
exercise capacity,78 the BODE (Body-Mass Index, Airflow Obstruction, Dyspnea, and 
Exercise Capacity) index,5 and mortality.9 A substantial number of patients with COPD, 
however, have significant discordance between spirometry and CT findings. We recently 
demonstrated that a biomechanical measure of structural lung disease (the Jacobian 
determinant, an elasticity measure of local lung volume change assessed through matching 
images acquired at multiple lung volumes) substantially explains the differences between 
static single-volume CT images and airflow obstruction on spirometry.1011 However, it 
remains important to determine if the Jacobian determinant is associated with standard 
clinical measures of patient outcomes. Such determination will enhance its use in better 
phenotyping patients. We analyzed data from a large subset of a well characterized cohort of 
participants with COPD who underwent clinical, physiological and radiographic 
assessments. We hypothesized that the mean Jacobian determinant, a measure of local tissue 
expansion and contraction, would provide additional explanation for the variations in 
clinically relevant outcomes including dyspnea, quality of life, functional capacity, and the 
BODE index, as well as all-cause mortality.
Methods
Patient selection
We analyzed participants enrolled in the Genetic Epidemiology of COPD (COPDGene) 
study, a large, ongoing, multicenter cohort study that includes current and former smokers 
aged 45 to 80 years, and without other chronic lung diseases except COPD and asthma. 
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Demographics were collected as per the COPDGene protocol via self-administered 
questionnaires. Details of the study protocol have been previously published.12 Post-
bronchodilator spirometry was performed using the ndd EasyOne spirometer to assess 
airflow obstruction. COPD was diagnosed using the ratio of forced expiratory volume in the 
first second (FEV1) to the forced vital capacity (FVC) of < 0.70, and severity categorized 
according to Global initiative for Chronic obstructive Lung Disease (GOLD) 
recommendations.13 All participants provided written informed consent and the research 
protocol was approved by the institutional review board at each participating center. The first 
1000 participants to enroll, and with complete image registration CT data, were included in 
the study reported here.
Morbidity data
Respiratory-related quality of life was assessed using the St. George’s Respiratory 
Questionnaire (SGRQ).14 Scores were calculated for the three main subdomains of the 
SGRQ: symptoms, activities and impact. Total score ranges from 0 to 100, with higher 
scores indicating worse quality of life. The minimum clinically important difference (MCID) 
for SGRQ is 4 units. Dyspnea was quantified using the modified Medical Research Council 
dyspnea score; the score ranges from 0 to 4, with greater score indicating worse dyspnea.15 
Exercise tolerance was assessed using the six minute walk distance (6MWD); MCID for the 
6MWD is 26 m.16 The multidimensional BODE index was finally calculated using body 
mass index, FEV1 %predicted, mMRC and 6MWD; the scale ranges from 0 to 10, with 
greater scores indicating a higher risk of mortality.17 We also obtained data on all-cause 
mortality on longitudinal follow-up of approximately 5 years.
CT Image Acquisition
Volumetric CT scans were acquired with the subject in the supine position during a carefully 
coached breath-hold to either full inspiration (total lung capacity; TLC) or end expiration 
(functional residual capacity; FRC). The scanning protocol included a collimation, 0.5mm; 
tube voltage, 120kV; tube current, 200mAs; gantry rotation time, 0.5s; and a pitch, 1.1. The 
images were reconstructed with a standard kernel (dependent upon the make and model of 
the scanner) and a slice thickness of 0.75mm and an interval of 0.5mm.
CT Image-based Measures
Densitometry—Using 3D Slicer software (www.airwayinspector.org), we measured 
emphysema and gas trapping based on density mask analyses.12 Emphysema was quantified 
by using the percentage of voxels at TLC with attenuation < −950 Hounsfield units (HU) 
and gas trapping was quantified as the low attenuation areas on FRC scan that are < −856 
HU. We used Pulmonary Workstation 2 (VIDA Diagnostics, Coralville, IA, USA) to 
measure the wall area percentage of segmental airways (WA%) that represent airway 
remodeling.12 The wall area percentage of segmental airways (WA%) was quantified at full 
inspiration CT image, and was estimated as (wall area/total bronchial area)×100. The mean 
WA% was calculated as the average of six segmental bronchi in each subject.
Image Registration—The full inspiration (TLC) and end expiration (FRC) scans were 
registered for each subject. Details of image registration are provided in the Supplement. 
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Briefly, a lung mass-preserving registration method was used to capture volume changes 
between the two phases of respiration.18 A sum of squared tissue volume difference 
(SSTVD) method was used as a similarity metric. This method has been shown previously to 
be effective in lung image registration protocols.1011 The transformation matrix from the 
registration process was used to derive regional tissue expansion and contraction measures 
between TLC and FRC volumes. In this study, we used the Jacobian determinant metric to 
represent regional deformation patterns in COPD patients. The Jacobian determinant 
measures the local volume change and estimates the pointwise expansion and contraction 
during deformation of the lung from TLC to FRC. This results in a deformation map that has 
values ranging from 0 to infinity. A Jacobian determinant value greater than 1 indicates local 
expansion whereas less than 1 indicates local contraction. A Jacobian determinant value 
equal to 1 indicates neither local expansion nor contraction. We used the mean of the 
Jacobian deformation map as a lung mechanical measure for each subject representing local 
deformation patterns between TLC and FRC volumes. Figure 1 shows representative 
Jacobian deformation maps for participants with different disease severity.
Statistical Analyses
We expressed all values as mean (standard deviation, SD). Pearson and Spearman 
correlation analyses were performed to assess the pairwise relationship of Jacobian 
determinant with SGRQ scores, BODE index, mMRC, 6MWD and FEV1. Association 
between Jacobian determinant and SGRQ was assessed using univariate and multivariable 
linear regression models after adjustment for age, sex, race, pack-years, BMI, FEV1, CT 
emphysema, CT gas trapping, WA%, and CT scanner type. As there was an 
overrepresentation of zero BODE scores, we used zero-inflated Poisson regression analyses 
to test the association between Jacobian determinant and the BODE index, after adjustment 
for the above mentioned variables, except for FEV1 and BMI as they are part of the BODE 
index. To calculate prediction of mortality on follow-up, we performed Cox proportional 
hazards analysis. Variables significant on univariate analysis at p<0.05 were entered into a 
multivariable Cox proportional hazards model to calculate adjusted hazards ratio for 
mortality for the Jacobian determinant; we forced CT scanner type into the model as this is 
clinically important. All tests of significance were two-tailed, and we considered an alpha 
level of <0.05 as statistically significant. All analyses were performed using Statistical 
Package for the Social Sciences (SPSS 22.0, SPSS Inc., Chicago, IL, USA) and R statistical 
software (version 3.2).
Results
Demographics
Of the first 1,000 participants to enroll, 562 participants had COPD GOLD stages 1 to 4. We 
excluded 72 participants due to image registration errors in boundary alignment. Table 1 
shows the baseline demographics, physiologic assessments, CT quantification of COPD and 
respiratory morbidity scores. The mean age of the participants was 64.6 (8.2) years. The 
cohort was comprised of 250 (51.1%) males and 240 (48.9%) non-Hispanic Whites. 
Participants had a substantial cigarette smoking burden with mean pack-years of 52.9 (26.1); 
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336 (68%) were active smokers at the time of enrollment. The participants encompassed the 
spectrum of disease severity, with 62 (12.7%), 204 (41.6%), 138 (28.2%) and 86 (17.6%) 
having GOLD severity stages 1 through 4 respectively. Distributions of SGRQ, 6MWD and 
the BODE index in the study population are shown in Supplemental Figure 2.
Correlation between the Jacobian measure and respiratory morbidity
Pair-wise relationship analysis between the Jacobian determinant and patient outcomes was 
performed. There was an inverse and statistically significant association between the 
Jacobian determinant and total SGRQ scores (r = −0.46; p<0.001), the BODE index (r = 
−0.60; p <0.001), and mMRC scores (r = −0.41; p <0.001). There was a positive association 
between the Jacobian determinant and the six-minute walk distance (r = 0.47; p <0.001) and 
FEV1 (r = 0.60; p <0.001).
CT measures and SGRQ
Table 2 shows univariate and multivariable associations between the CT metrics of 
emphysema, gas trapping, WA% and the Jacobian measure with SGRQ. On univariate 
regression, the Jacobian determinant was significantly associated with SGRQ (unadjusted 
regression co-efficient β=−38.1, 95%CI= −46.8 to −29.2; p<0.001); this relationship held 
true after adjustment for age, sex, race, BMI, FEV1, smoking pack years, CT emphysema, 
CT gas trapping, airway wall area (WA%), and CT scanner type (β=−11.75, 95%CI= −21.6 
to −1.7; p=0.020).
CT measures and 6MWD
The relationship between CT metrics and the 6MWD is shown in Table 3. On univariate 
analysis, the Jacobian measure was significantly associated with distance walked (β=770.1, 
95%CI= 600.0 to 940.1; p<0.001); this association was maintained after multivariable 
adjustment (β=321.15, 95%CI= 134.1 to 508.1; p<0.001).
CT measures and BODE index
Table 4 shows the relationships between CT metrics and BODE index. The Jacobian 
determinant was significantly associated with the BODE index on univariate analysis (β= 
−1.77, 95%CI= −2.04 to −1.51; p<0.001), and after adjustment for age, sex, race, smoking 
pack-years, CT emphysema, CT gas trapping, airway wall area percent, and CT scanner type 
(β= −0.4, 95%CI= −0.8 to −0.01; p = 0.039).
CT measures and mortality
We had follow-up data for 441 of the 490 participants for a median of 6.8 years (interquartile 
range 6.6 to 6.9). Of these, 99 (22.4%) died on follow-up. On univariate analyses, all CT 
measures were associated with all-cause mortality; unadjusted hazards ratio (HR) for CT 
emphysema 1.03 (95%CI 1.02 to 1.05; p<0.001), CT gas trapping 1.03 (95%CI 1.02 to 1.04; 
p<0.001), WA% 1.08 (95%CI 1.01 to 1.15; p<0.001) and Jacobian determinant 13.16 
(95%CI 4.52 to 38.46; p<0.001). After adjustment for age, pack-years of smoking, FEV1, 
CT gas trapping, WA% and CT scanner type, CT emphysema was not associated with 
mortality (adjusted HR = 1.01, 95%CI 0.98 to 1.04; p =0.446). WA% and CT gas trapping 
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were also not independently associated with mortality (adjusted HR = 1.05, 95%CI 0.96 to 
1.14; p=0.315 and 1.01, 95%CI 0.98 to 1.04; p=0.424, respectively). After adjustment for 
age, pack-years of smoking, FEV1, CT emphysema, CT gas trapping, WA% and CT scanner 
type, the Jacobian determinant approached statistical significance for association with 
mortality (adjusted HR = 4.26, 95%CI = 0.93 to 19.23; p = 0.064).
Discussion
We demonstrated a strong relationship between the Jacobian determinant mean, a 
biomechanical elasticity measure of regional parenchymal volume change, and important 
patient outcomes including dyspnea, respiratory quality of life, functional capacity and the 
BODE index, and mortality. On multivariable analyses, we found that the effect size of a 
unit change in the Jacobian determinant is stronger than the effect sizes of static single-
volume CT measures of COPD such as emphysema percentage, gas trapping and airway 
wall thickness, thus providing novel and independent information applicable to COPD 
phenotyping and prognosis.
It is well established that there is, at best, a modest correlation between FEV1, the primary 
measure of disease severity in COPD, and clinical outcomes such as respiratory health-
related quality of life and dyspnea,1920 and FEV1 does not fully explain the morbidity 
associated with COPD. In this regard, our findings extend the results of other recent studies 
that demonstrated a relationship between CT metrics of COPD and clinically relevant 
outcomes. Although lung function impairment is correlated with poor functional outcomes, 
SGRQ is influenced by a number of factors that are not fully explained by FEV1 such as 
cough and exacerbations. Grydeland and colleagues demonstrated that CT indices of 
emphysema and airway disease improved the prediction of respiratory symptoms over 
spirometry alone.4 Gietema et al. showed that both airway wall thickness and emphysema 
are independently associated with respiratory-quality of life, 6 and Martinez et al. reported 
that there was a stronger association between SGRQ and airway wall thickness than between 
SGRQ and CT emphysema.5 On the other hand, they also found that the BODE index was 
influenced more by emphysema than by airway wall thickness. Other studies have also 
found significant associations between measures of emphysema and airflow obstruction, 
exercise tolerance and dyspnea.237821
The possible reasons for why the Jacobian determinant shows independent associations with 
outcomes merits discussion. FEV1 is a global measure of lung function impairment and is 
influenced by both airway narrowing and decreased lung elastic recoil associated with 
emphysema. However, in a given patient, it is usual to see multiple subtypes of emphysema 
such as centrilobular and panlobular emphysema with differential impact on lung 
function.22–24 The degree of CT emphysema does not translate linearly into airflow 
obstruction,310 and it is likely that different types and distribution patterns of emphysema 
contribute differentially to airflow obstruction.22–24 Although we did not study emphysema 
subtypes, the mean Jacobian determinant, by offering information of regional volume 
change with respiration, likely reflects a more direct physiologic link between structural 
lung disease and the lung mechanics reflected by spirometry. Previous studies found that 
imaging metrics offered marginal additional, albeit independent information, over that 
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offered by spirometry in the prediction of respiratory quality of life. However, we showed 
that CT-based metrics derived from image-matching offer information that are not only 
independent and additive, but with effect sizes greater than FEV1 for all the outcomes 
studied. In addition, dyspnea contributes significantly to respiratory quality of life as well as 
reduction in functional capacity, and even patients with relatively preserved FEV1 can 
experience significant dyspnea and hence a poorer quality of life. This could be due to 
factors other than FEV1 such as poorer diaphragmatic position due to resting as well as 
dynamic hyperinflation, both of which might be reflected better by changes in regional 
volume change than by static single-volume CT measures of emphysema and airway 
disease. Our findings provide new insight into the complex pathophysiological basis and the 
heterogeneity of causes of changes in dyspnea and SGRQ. These findings are pertinent as 
dyspnea and SGRQ are frequently used as outcome measures in clinical trials of 
pharmacologic and non-pharmacologic therapies, once again highlighting the importance of 
phenotyping COPD patients.
We also showed that the Jacobian estimate of local lung volume change was significantly 
associated with the BODE index which predicts all-cause and respiratory-specific mortality 
in COPD.17 The association between mean Jacobian determinant and mortality approached 
statistical significance. This is a novel finding and adds to the findings of previous studies 
which demonstrated a relationship between CT emphysema and both the BODE index and 
mortality.5925 Our findings are aligned with those of Martinez et al who found that CT 
emphysema was not associated with mortality,26 but are on contrast to those of Johannessen 
et al who found that patients with more severe emphysema are higher mortality compared to 
those with mild emphysema.9 It is unclear whether the poorer mechanics are a more 
sensitive reflector of underlying emphysema that has been shown to be independently 
associated with poor outcomes and mortality,27 or if the affected lung mechanics have an 
independent role in disease progression and mortality. Of note, lung volume reduction 
surgery improves symptoms and mortality in a subset of patients,28 and it is plausible that 
the benefits of lung volume reduction are largely due to improved lung elasticity in the 
ipsilateral preserved lobe.29
One of the limitations of our study is that the CT scans were not spirometrically 
controlled.3031 As varying respiratory effort can affect the reproducibility of image-
registration metrics, participants were coached to maximum inhalation and end expiration. 
As this was a multicenter trial, a number of different scanners were used for image 
acquisition; however, we adjusted for scanner variability. For calculating the Jacobian 
determinant, CT scans were obtained at only two volumes. Although this limited our ability 
to assess regional differences in lung mechanics along the entire spectrum of lung inflation 
and deflation,32 our metrics are applicable to clinically obtained scans without the excessive 
radiation risks that would incurred in acquiring dynamic scans. We did not have mortality 
data in some participants and this could have introduced some selection bias, however we 
had survival data on most participants. Our study was strengthened by the inclusion of 
participants enrolled in a large well characterized cohort of current and former smokers that 
included a high proportion of African Americans.
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In conclusion, biomechanical metrics of local lung expansion and contraction offer better 
prediction of respiratory quality of life, the BODE index and mortality, and offer additional 
prognostic information beyond traditional measures of lung function and static single-
volume CT metrics. Traditional CT measures have been used to phenotype COPD, and the 
implications of these phenotyping metrics have been assessed by correlating with relevant 
clinical outcomes. Thus, the Jacobian determinant, by offering additional information on 
lung disease in COPD, and by showing additional associations with clinically relevant 
outcomes, can add to our ability to phenotype COPD patients based on the complex 
pathophysiological heterogeneity that extends beyond lung function measures alone.
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What is the key question?
Traditional metrics of lung disease such as spirometry and static single-volume CT 
images are used to explain respiratory morbidity in patients with chronic obstructive 
pulmonary disease (COPD). However, there is substantial discordance in individual 
patients between these metrics and respiratory morbidity. Can biomechanical measures of 
local lung expansion and contraction offer additional prognostic information in COPD?
What is the bottom line?
We demonstrate that biomechanical metrics of local lung expansion and contraction offer 
additional information beyond traditional measures of lung function and static single-
volume CT metrics in the prediction of respiratory morbidity and all-cause mortality.
Why read on?
Independent prognostic information offered by biomechanical measures will help 
improve prognostication and phenotyping patients with COPD.
Bodduluri et al. Page 11
Thorax. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Panels a and b show axial CT section and the corresponding deformation map respectively 
for a representative participant with GOLD 1 with low BODE index. Panels c and d show 
similar images for a representative participant with GOLD 4 COPD and high BODE index. 
The colors depict the Jacobian deformation map from full inspiration to end expiration and 
show the variability in regional tissue expansion patterns across both subjects. Jacobian 
determinant = 1 represents no deformation; >1 = local expansion; and <1 = local 
contraction.
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Table 1
Baseline demographics, physiologic assessments, CT quantification of COPD and morbidity scores
Parameter Mean (SD)
Age (years) 64.6 (8.2)
Female (%) 240 (49)
African American (%) 78 (16)
BMI (kg/m2) 27.5 (5.8)
Smoking pack-years 52.9 (26.1)
Current Smokers (%) 336(68)
FEV1 (L) 1.49 (0.7)
FEV1 % Predicted 53.2 (22.0)
FVC (L) 2.96 (1.0)
FVC % Predicted 80.0 (21.3)
FEV1/FVC 0.49 (0.12)
CT Emphysema (%) 12.4 (12.1)
CT Gas Trapping (%) 37.9 (20.3)
Airway Wall Area (%), segmental airways 62.3 (3.1)
SGRQ (Total Score) 37.6 (22.4)
6MWD (m) 360 (145)
BODE index# 3 (1–5)
mMRC score# 2 (1–3)
All values expressed as mean (standard deviation) or as percentage, except # where median (interquartile range) are depicted. BMI = Body Mass 
Index; FEV1 = Forced expiratory volume in the first second; FVC = Forced vital capacity; CT = Computed tomography; SGRQ = St George’s 
Respiratory Questionnaire; 6MWD = Six minute walk distance; BODE index = BMI, Airflow Obstruction, Dyspnea and Exercise capacity; mMRC 
= Modified Medical Research Council dyspnea scale.
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Table 2
Univariate and multivariable associations of mean Jacobian determinant measure with SGRQ
Parameter Univariate Regression Multivariable Regression
Regression co-efficient β (95%CI) P value Regression co-efficient β (95%CI) P value
Mean Jacobian determinant −38.08 (−46.8, −29.2) < 0.001 −11.75 (−21.6, −1.7) 0.020
Age (years) −0.50 (−0.7, −0.2) < 0.001 −0.68 (−0.9, −0.4) < 0.001
African American race 12.22 (6.9, 17.5) < 0.001 6.73 (1.6, 11.7) 0.009
Female sex −0.91 (−4.9, 3.0) 0.652 −1.69 (−5.5, 2.1) 0.390
BMI (kg/m2) 0.21 (−0.1, 0.5) 0.219 0.39 (0.0, 0.7) 0.013
FEV1 (L) −15.4 (−17.8, −13.2) < 0.001 −10.65 (−14.2, −7.0) < 0.001
Smoking pack-years 0.11 (0.03, 0.18) 0.003 0.16 (0.1, 0.2) < 0.001
CT Emphysema (%) 0.57 (0.4, 0.7) < 0.001 0.33 (0.0, 0.5) 0.002
CT Gas Trapping (%) 0.44 (0.3, 0.5) < 0.001 −0.01 (−0.1, 0.1) 0.990
Airway Wall Area, (%) 2.51 (1.8, 3.1) < 0.001 0.95 (0.3, 1.5) 0.002
SGRQ = St George’s Respiratory Questionnaire; BMI = Body mass index; FEV1 = Forced expiratory volume in the first second; CT = Computed 
tomography. Multivariable regression model adjusted for CT scanner type.
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Table 3
Univariate and multi-variate association of mean Jacobian determinant measure with six minute distance 
walked (6MWD)
Parameter Univariate Regression Multivariable Regression
Regression co-efficient β (95%CI) P value Regression co-efficient β (95%CI) P value
Mean Jacobian determinant 770.10 (600.0, 940.1) < 0.001 321.15 (134.1, 508.1) < 0.001
Age (years) −2.75 (−7.4, 1.9) 0.251 −3.52 (−7.7, 0.6) 0.097
African American race −331.10 (−431.6, −230.5) < 0.001 −290.51 (−385.6, −195.3) < 0.001
Female sex −74.66 (−151.8, 2.49) 0.057 −31.00 (−103.6, 41.6) 0.402
BMI (kg/m2) −7.07 (−13.6, −0.5) 0.035 −10.79 (−16.6, 41.6) < 0.001
FEV1 (L) 315.72 (270.7, 360.6) < 0.001 204.08 (136.2, 271.9) < 0.001
Smoking pack-years −1.18 (−2.6, 0.2) 0.115 −2.14 (−3.3, −0.9) < 0.001
CT Emphysema (%) −8.19 (−11.3, −5.0) < 0.001 −7.26 (−11.8, −2.6) 0.001
CT Gas Trapping (%) −7.10 (−9.0, −5.1) < 0.001 2.95 (−0.3, 6.2) 0.081
Airway Wall Area (%) −40.24 (−52.3, −28.2) < 0.001 −12.03 (−23.5, −0.5) 0.040
BMI = Body mass index. FEV1 = Forced expiratory volume in the first second. CT = Computed tomography. Multivariable regression model 
adjusted for CT scanner type.
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Table 4
Univariate and multivariable associations of mean Jacobian determinant measure with BODE index
Parameter Univariate Regression Multivariable Regression
Regression co-efficient β (95%CI) P value Regression co-efficient β (95%CI) P value
Mean Jacobian determinant −1.77 (−2.044, −1.507) < 0.001 −0.41 (−0.803, −0.019) 0.039
Age (years) −0.004 (−0.010, 0.002) 0.189 −0.04 (−0.014, 0.001) 0.054
African American race 0.22 (0.083, 0.350) 0.001 0.16 (−0.008, 0.325) 0.059
Female sex −0.01 (−0.112, 0.082) 0.783 0.15 (0.040, 0.275) 0.008
Smoking pack-years 0.002 (0.003, 0.004) 0.013 0.00 (0.001, 0.005) 0.001
CT Emphysema (%) 0.02 (0.021, 0.029) < 0.001 0.01 (0.003, 0.018) 0.003
CT Gas Trapping (%) 0.02 (0.023, 0.028) < 0.001 0.01 (0.009, 0.020) < 0.001
Airway Wall Area (%) 0.08 (0.064, 0.102) < 0.001 0.07 (0.050, 0.089) < 0.001
BODE index = BMI, Airflow Obstruction, Dyspnea and Exercise capacity; BMI = Body mass index. CT = Computed tomography. Multivariable 
regression model adjusted for CT scanner type.
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